Journals / Turkish Journal of Pharmaceutical Sciences / 2016 / Cilt: 13 - Sayı: 3

Formulation and Evaluation of Lansoprazole Loaded Nanosponges

Lasoprazol Yüklü Nanosüngerlerin Formülasyonu ve Değerlendirilmesi

Pages
304–310
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The data obtained in this study suggests that nanosponges of lansoprazole are promising for controlled drug delivery, whichcan reduce dosing frequency.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Lansoprazole is proton pump inhibitor which extensively degraded in acidic pH conditions.
📊
Key Findings & Data:Lansoprazole loaded nanosponges were prepared byEmulsion solvent diffusion method using ethylcellulose, PVA and pluronic F-68 and dichloromethane as a solvent.
💡
Conclusion & Impact:The data obtained in this study suggests that nanosponges of lansoprazole are promising for controlled drug delivery, whichcan reduce dosing frequency.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Lansoprazole is proton pump inhibitor which extensively degraded in acidic pH conditions. Lansoprazole loaded nanosponges were prepared byEmulsion solvent diffusion method using ethylcellulose, PVA and pluronic F-68 and dichloromethane as a solvent. The prepared nanospongeswere evaluated for percentage yield, incorporation efficiency, particle size, drug polymer compatibility, scanning electron microscopy and invitro drug release. SEM studies confirmed their porous structure with number of nanochannels. The FTIR spectra showed stable characterof lansoprazole in mixture of polymers and revealed the absence of drug polymer interactions. DSC study revealed that drug was involved incomplexation with nanosponges. The average particle size of lansoprazole nanoparticles was found to be in the range of 83.4 nm to 190.69 nm.The negative zeta potential values were attained to ensure a good stability of nanosponges. The drug release from nanosponges was foundto extended upto 12 h. The optimized nanosponges were formulated in to enteric coated tablet and evaluated for weight variation, hardness,friability and dissolution studies. In-vitro release of drug from enteric coated tablet follows zero order and showed controlled release behaviorfor a period of 24 h. The data obtained in this study suggests that nanosponges of lansoprazole are promising for controlled drug delivery, whichcan reduce dosing frequency.

Özet

Lansoprazol asidik pH koşullarında yoğun şekilde bozulan proton pompası inhibitörüdür. Lansoprazol yüklü nanosüngerler etilselüloz, PVA ve pluronic F68 ve solvan olarak da diklorometan kullanılarak emülsiyon çözücü difüzyon metodu ile hazırlandı. Hazırlanan nanosüngerler yüzde verim, yükleme etkinliği, partikül büyüklüğü, etkin madde polimer geçimliliği, taramalı elektron mikroskobu ve in vitro ekin madde salımı açısından değerlendirildi. SEM çalışmaları çok sayıda nanokanallar ile poröz yapılarını doğruladı. FTIR spektrumu polimer karışımı içinde lansoprazolün stabilitesini ve etkin madde polimer etkileşimi olmadığını gösterdi. DSC çalışması etkin maddenin nanosüngerle kompleks halinde olduğu ortaya çıkardı. Lansoprazol nanopartiküllerin ortalama partikül büyüklüğü 83.4 nm ile 190.69 nm aralığında bulundu. Negatif zeta potansiyel değerlerine ulaşılması nanosüngerlerin iyi stabilite göstermelerini sağladı. Etkin maddenin nanosüngerlerden salımının 12 saate kadar uzatıldığı bulundu. Optimize edilmiş nanosüngerler enterik kaplı tabletler halinde formüle edildi ve ağırlık sapması, sertlik, friabilite ve çözünme çalışmaları değerlendirildi. Enterik kaplı tabletlerden etkin maddenin in vitro salımı sıfır dereceye uyumlu ve 24 saatlik periyotda kontrollü salım davranışı gösterdi. Bu çalışmadan elde edilen veriler gösterdi ki lansoprazol nanosüngerleri doz sıklığını azaltabilecek kontrollü salım için gelecek vaad etmektedir.

🔖

Cite This Article

RAVOURU, N., DAMINEN, S., POREDDY, S. R., BNS, S., PENJURI, S. C. B. (2022). Formulation and Evaluation of Lansoprazole Loaded Nanosponges. Turkish Journal of Pharmaceutical Sciences, Cilt: 13 - Sayı: 3, 304–310. https://ajindex.com/articles/613884

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Vyas SP, Khar RK. Novel Carrier Systems. Molecular Basis of Targeted Drug Delivery. In: Targeted and Controlled Drug Delivery, pp. 38-40, CBS Publishers and Distributors, New Delhi, 2008
  2. Jilsha G, Vidya Viswanad. Nanosponges: A Novel Approach of Drug Delivery System. Int J Pharm Sci Rev Res 19(2), 119-123, 2013
  3. Lala R, Thorat A, Gargote C. Current trends in β- cyclodextrin based drug delivery systems. Int J Res Ayur Pharm 2(5), 1520-1526, 2011
  4. Jenny A, Merima P, Alberto F, Francesco T. Role of β-cyclodextrin nanosponges in propylene photooxidation. Carbohydrate Polymers. 86(1), 127-135, 2011
  5. Renuka Sharma, Roderick BW, Kamla Pathak. Evaluation of kinetics and mechanism of drug release from econazole nitrate nanosponge loaded carbapol hydrogel. Ind J Pham Edu Res 45(1), 25-31, 2011
  6. Matheson AJ and Jarvis B. Lansoprazole: an update of its place in the management of acid-related disorder. Drugs 61(2), 1801-1833, 2001
  7. Nagarajan E, Shanmugasundaram P, Ravichandirana V, Vijayalakshmi A, Senthilnathan B, Masilamani K, Development and evaluation of chitosan based polymeric nanoparticles of an antiulcer drug lansoprazole. J App Pharm Sci 5(4), 20-25, 2015
  8. Shimizu T, Nakano Y, Morimoto S, Tabata T, Hamaguchi N, Igari Y. Formulation study for Lansoprazole fast-disintegrating tablet. I. Effect of compression on dissolution behavior. Chem Pharm Bull 51(8), 942- 947, 2003
  9. Venkateswarlu P. Formulation and In Vitro Evaluation of Lansoprazole Delayed Release Capsules Int J Innov Pharm Sci Res 4(3), 328-336, 2013
  10. Cavalli R, Trotta F, Tumiatti W. Cyclodextrin-based Nanosponges for Drug Delivery. J Incl Phenom Macrocycl Chem 56(1-2), 209-213, 2006
  11. Swaminathan S, Linda P, Loredana S, Francesco T, Pradeep V, Dino A, Michele T, Gianpaolo Z, Roberta C. Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization stability and cytotoxicity. Eur J Pharm Biopharm 74(2), 193-201, 2010
  12. Swaminathan S, Pradeep V, Trotta F, Cavalli R. Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability. J Biomed Nanotechnol 9(6), 998-1007, 2013
  13. Prasanna Reddy Battu, Reddy MS. Residual solvents determination by HS-GC with flame ionization detector in omeprazole pharmaceutical formulations. Int J PharmTech Res 1(2), 230-234, 2009
  14. Bajpai M, Singh DCP, Bhattacharya A, Singh A. Design and in vitro evaluation of compression-coa